drugset / Trial / NCT00631852

A Phase II Biomarker Trial of Gelatin Encapsulated Extract of American Ginseng Root (LEAG) in Breast Cancer

NCT00631852

Phase 2 Completed 16 enrolled Southern Illinois University
NaSingle-groupOpen-labelTreatment

Summary

This study was designed to explore the changes brought about by gelatin encapsulated extract of American Ginseng Root (LEAG) in breast cancer tumors and surrounding normal breast epithelial cells. Various tumor biomarkers, as well as inflammatory mediators, will be examined in tissue following LEAG treatment.

Timeline

Start
2008-02
Primary completion
2019-06-30
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject American ginseng Unknown 250 mg

Indications